Clinical utility of family history for cancer screening and referral in primary care: A report from the Family Healthware Impact Trial

Wendy S. Rubinstein, Louise S. Acheson, Suzanne M. O'Neill, MacK T. Ruffin, Catharine Wang, Jennifer L. Beaumont, Nan Rothrock

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Purpose: To assess the effectiveness of computerized familial risk assessment and tailored messages for identifying individuals for targeted cancer prevention strategies and motivating behavior change. Methods: We conducted a randomized clinical trial in primary care patients aged 35-65 years using Family Healthware, a self-administered, internet-based tool that collects family history for six common diseases including breast cancer, colon cancer, and ovarian cancer, stratifies risk into three tiers, and provides tailored prevention messages. Cancer screening adherence and consultation were measured at baseline and 6-month follow-up. Results: Of 3283 participants, 34% were at strong or moderate risk of at least one of the cancers. Family Healthware identified additional participants for whom earlier screening (colon cancer, 4.4%; breast cancer, women ages: 35-39 years, 9%) or genetic assessment (colon cancer, 2.5%; breast cancer, 10%; and ovarian cancer, 4%) may be indicated. Fewer than half were already adherent with risk-based screening. Screening adherence improved for all risk categories with no difference between intervention and control groups. Consultation with specialists did not differ between groups. Conclusion: Family Healthware identified patients for intensified cancer prevention. Engagement of clinicians and patients, integration with clinical decision support, and inclusion of nonfamilial risk factors may be necessary to achieve the full potential of computerized risk assessment.

Original languageEnglish (US)
Pages (from-to)956-965
Number of pages10
JournalGenetics in Medicine
Volume13
Issue number11
DOIs
StatePublished - Nov 1 2011

Fingerprint

Early Detection of Cancer
Colonic Neoplasms
Primary Health Care
Referral and Consultation
Breast Neoplasms
Ovarian Neoplasms
Clinical Decision Support Systems
Patient Participation
Neoplasms
Internet
Randomized Controlled Trials
Control Groups

All Science Journal Classification (ASJC) codes

  • Genetics(clinical)

Cite this

Rubinstein, Wendy S. ; Acheson, Louise S. ; O'Neill, Suzanne M. ; Ruffin, MacK T. ; Wang, Catharine ; Beaumont, Jennifer L. ; Rothrock, Nan. / Clinical utility of family history for cancer screening and referral in primary care : A report from the Family Healthware Impact Trial. In: Genetics in Medicine. 2011 ; Vol. 13, No. 11. pp. 956-965.
@article{c110c6f023b7490dafa8fad6c2a9e807,
title = "Clinical utility of family history for cancer screening and referral in primary care: A report from the Family Healthware Impact Trial",
abstract = "Purpose: To assess the effectiveness of computerized familial risk assessment and tailored messages for identifying individuals for targeted cancer prevention strategies and motivating behavior change. Methods: We conducted a randomized clinical trial in primary care patients aged 35-65 years using Family Healthware, a self-administered, internet-based tool that collects family history for six common diseases including breast cancer, colon cancer, and ovarian cancer, stratifies risk into three tiers, and provides tailored prevention messages. Cancer screening adherence and consultation were measured at baseline and 6-month follow-up. Results: Of 3283 participants, 34{\%} were at strong or moderate risk of at least one of the cancers. Family Healthware identified additional participants for whom earlier screening (colon cancer, 4.4{\%}; breast cancer, women ages: 35-39 years, 9{\%}) or genetic assessment (colon cancer, 2.5{\%}; breast cancer, 10{\%}; and ovarian cancer, 4{\%}) may be indicated. Fewer than half were already adherent with risk-based screening. Screening adherence improved for all risk categories with no difference between intervention and control groups. Consultation with specialists did not differ between groups. Conclusion: Family Healthware identified patients for intensified cancer prevention. Engagement of clinicians and patients, integration with clinical decision support, and inclusion of nonfamilial risk factors may be necessary to achieve the full potential of computerized risk assessment.",
author = "Rubinstein, {Wendy S.} and Acheson, {Louise S.} and O'Neill, {Suzanne M.} and Ruffin, {MacK T.} and Catharine Wang and Beaumont, {Jennifer L.} and Nan Rothrock",
year = "2011",
month = "11",
day = "1",
doi = "10.1097/GIM.0b013e3182241d88",
language = "English (US)",
volume = "13",
pages = "956--965",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

Clinical utility of family history for cancer screening and referral in primary care : A report from the Family Healthware Impact Trial. / Rubinstein, Wendy S.; Acheson, Louise S.; O'Neill, Suzanne M.; Ruffin, MacK T.; Wang, Catharine; Beaumont, Jennifer L.; Rothrock, Nan.

In: Genetics in Medicine, Vol. 13, No. 11, 01.11.2011, p. 956-965.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical utility of family history for cancer screening and referral in primary care

T2 - A report from the Family Healthware Impact Trial

AU - Rubinstein, Wendy S.

AU - Acheson, Louise S.

AU - O'Neill, Suzanne M.

AU - Ruffin, MacK T.

AU - Wang, Catharine

AU - Beaumont, Jennifer L.

AU - Rothrock, Nan

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Purpose: To assess the effectiveness of computerized familial risk assessment and tailored messages for identifying individuals for targeted cancer prevention strategies and motivating behavior change. Methods: We conducted a randomized clinical trial in primary care patients aged 35-65 years using Family Healthware, a self-administered, internet-based tool that collects family history for six common diseases including breast cancer, colon cancer, and ovarian cancer, stratifies risk into three tiers, and provides tailored prevention messages. Cancer screening adherence and consultation were measured at baseline and 6-month follow-up. Results: Of 3283 participants, 34% were at strong or moderate risk of at least one of the cancers. Family Healthware identified additional participants for whom earlier screening (colon cancer, 4.4%; breast cancer, women ages: 35-39 years, 9%) or genetic assessment (colon cancer, 2.5%; breast cancer, 10%; and ovarian cancer, 4%) may be indicated. Fewer than half were already adherent with risk-based screening. Screening adherence improved for all risk categories with no difference between intervention and control groups. Consultation with specialists did not differ between groups. Conclusion: Family Healthware identified patients for intensified cancer prevention. Engagement of clinicians and patients, integration with clinical decision support, and inclusion of nonfamilial risk factors may be necessary to achieve the full potential of computerized risk assessment.

AB - Purpose: To assess the effectiveness of computerized familial risk assessment and tailored messages for identifying individuals for targeted cancer prevention strategies and motivating behavior change. Methods: We conducted a randomized clinical trial in primary care patients aged 35-65 years using Family Healthware, a self-administered, internet-based tool that collects family history for six common diseases including breast cancer, colon cancer, and ovarian cancer, stratifies risk into three tiers, and provides tailored prevention messages. Cancer screening adherence and consultation were measured at baseline and 6-month follow-up. Results: Of 3283 participants, 34% were at strong or moderate risk of at least one of the cancers. Family Healthware identified additional participants for whom earlier screening (colon cancer, 4.4%; breast cancer, women ages: 35-39 years, 9%) or genetic assessment (colon cancer, 2.5%; breast cancer, 10%; and ovarian cancer, 4%) may be indicated. Fewer than half were already adherent with risk-based screening. Screening adherence improved for all risk categories with no difference between intervention and control groups. Consultation with specialists did not differ between groups. Conclusion: Family Healthware identified patients for intensified cancer prevention. Engagement of clinicians and patients, integration with clinical decision support, and inclusion of nonfamilial risk factors may be necessary to achieve the full potential of computerized risk assessment.

UR - http://www.scopus.com/inward/record.url?scp=79960191924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960191924&partnerID=8YFLogxK

U2 - 10.1097/GIM.0b013e3182241d88

DO - 10.1097/GIM.0b013e3182241d88

M3 - Article

C2 - 22075527

AN - SCOPUS:79960191924

VL - 13

SP - 956

EP - 965

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 11

ER -